Gut

Gut
Audio Summaries

Every issue of Gut moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

131 audio summariesNLM Catalog

Specialties

Gut covers research in these specialties.

Recent summaries

The latest articles summarized from Gut.

Short-term risk prediction model for pancreatic cancer in type 2 diabetes: development and validation across two independent Chinese cohorts

Oct 6, 2026

The authors aimed to develop and validate a short-term risk prediction model for pancreatic cancer, specifically for individuals with both new-onset and long-standing type 2 diabetes. Utilizing two independent Chinese cohorts, they created the STOP-DM model, which demonstrated high predictive performance, particularly at the 6-month mark, and effectively identified high-risk individuals for targeted screening. The findings suggest that the STOP-DM model could enhance pancreatic cancer risk stratification and screening efficiency in diabetic populations.

Microbiota-host genetic interactions modulate MASLD risk in <em>PNPLA3<sup>I148M</sup></em> carriers via ceramides and are reversible by targeted microbial interventions

Oct 5, 2026

The authors investigate how disruptions in the intestinal host-microbiota interface influence the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) in carriers of the PNPLA3 I148M variant. Their findings reveal that impaired gut barrier function exacerbates hepatic injury through increased levels of microbiota-associated metabolites, suggesting that targeting the microbiota could be a viable strategy to mitigate MASLD progression in genetically susceptible individuals.

Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience

Oct 1, 2026

The authors of this study aimed to evaluate the prognostic role of circulating tumor DNA (ctDNA) in detecting minimal residual disease (MRD) in colorectal cancer patients and to assess the lead time for recurrence detection through longitudinal MRD testing. Their findings indicate that ctDNA testing is valuable for risk stratification, revealing a higher recurrence rate in MRD-positive patients and improved sensitivity for recurrence detection with multitimepoint testing. The study highlights the need for further interventional research to establish the clinical utility and optimal implementation of ctDNA testing in practice.

Regulatory T cells in autoimmune liver diseases

Oct 1, 2026

This review aims to elucidate the role of regulatory T cells (Tregs) in autoimmune liver diseases (AILDs) by examining their altered function and abundance in various disease contexts. The authors synthesize evidence from human studies and preclinical models to highlight the heterogeneity of Treg characteristics across different AILDs and the impact of the immune microenvironment on Treg stability and function. Additionally, they discuss current and emerging therapeutic strategies targeting Tregs, addressing challenges for clinical application and outlining priorities for future research.

Rewinding the gut clock: from chronodisruption to targeted therapies

Sep 30, 2026

The authors investigate how chronodisruption, caused by misaligned circadian rhythms due to modern lifestyle factors, affects gastrointestinal (GI) health and metabolic disorders. They explore potential therapeutic strategies, such as time-restricted feeding and chronobiotics, aimed at restoring circadian alignment to improve metabolic health and prevent GI diseases. The paper highlights the importance of understanding circadian biology for developing personalized medicine approaches to address these health issues.

Hypothermic oxygenated and normothermic machine perfusion mitigate innate systemic and hepatic inflammation after liver transplantation

Sep 29, 2026

The authors aimed to investigate the immunological effects of hypothermic oxygenated (HOPE) and normothermic machine perfusion (NMP) compared to static cold storage (SCS) in liver transplantation, specifically focusing on innate systemic and hepatic inflammation. Their findings indicate that both HOPE and NMP significantly reduce neutrophil infiltration and modulate immune responses, leading to decreased inflammation and improved recovery of lymphocyte populations in recipients. This study highlights the potential of machine perfusion techniques to enhance immune regulation and mitigate ischaemia-reperfusion injury in liver transplant patients.

EUropean consensus on the Resolution Of SympToms After oesophago-gastric Resection (EUROSTAR): Peri-Operative Quality Initiative (POQI) consensus statement

Sep 25, 2026

The authors aimed to address the lack of standardization in the definition, investigation, and management of postoperative symptoms following upper gastrointestinal (UGI) cancer surgery. Through a series of consensus meetings involving multidisciplinary experts, they developed eight statements and thirteen recommendations to improve symptom monitoring and care for patients, alongside identifying sixteen future research priorities. The resulting EUROSTAR consensus aims to enhance survivorship care and guide further research in this area.

Expert consensus on clinical trials for use of systemic therapy in patients with hepatocellular carcinoma undergoing surgical and locoregional therapies

Sep 24, 2026

The authors convened a multidisciplinary panel to establish expert consensus on the design of clinical trials evaluating systemic therapy in patients with hepatocellular carcinoma (HCC) undergoing surgical and locoregional therapies. They aimed to address challenges in trial design due to the heterogeneity of HCC by defining inclusion criteria, risk stratification, treatment strategies, and appropriate endpoints. The consensus emphasizes the importance of selecting high-risk patient populations and using clinically relevant outcomes to rigorously assess the efficacy and safety of these therapies.

Metastatic pancreatic cancer: from human disease to preclinical modelling

Sep 24, 2026

The authors aim to elucidate the complexities of metastatic pancreatic ductal adenocarcinoma (PDAC), focusing on its clinical features, molecular heterogeneity, and the interactions between cancer cells and their microenvironments that complicate diagnosis and treatment. They review current preclinical models and highlight the limitations and future opportunities in precision oncology to improve clinical strategies against PDAC metastasis. Ultimately, the paper seeks to advance understanding and management of this lethal cancer type.

Butyrylcholinesterase alleviates hepatic stellate cell activation via paracrine muscarinic signalling

Sep 23, 2026

The authors investigate the role of butyrylcholinesterase (BuChE) in regulating fibrosis through its effect on acetylcholine (ACh) bioavailability and downstream cholinergic signaling in hepatic stellate cells (HSCs). They find that reduced BuChE expression correlates with increased HSC activation and fibrosis, while BuChE overexpression has a protective effect. The study identifies a novel cholinergic circuit involving ChRM3 signaling that could serve as a therapeutic target for fibrosis treatment.

Listen to Gut

14-day free trial. Every new article, summarized in ~3 minutes.